NCT00252200View on ClinicalTrials.gov

BNP (Nesiritide) vs. Placebo to Protect Kidney Function in Patients Undergoing Heart Bypass Surgery.

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Acute Kidney Failure
Interventions
DRUG

Neseritide

Dose of Nesiritide infusion will be 0.005 ug/Kg/min

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

Scios, Inc.

INDUSTRY

lead

Mayo Clinic

OTHER